logo
Select company
Select metric
$ -11.69MConsolidated Income
VS
Market
34
Sector
65
Industry
53
History
-
$ 2.66Close
$ 2.45 - $ 65.4 52-Week Range
Ticker Information

Ticker

BIAF

Company Name

BIOAFFINITY TECHNOLOGIES INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

BIOAFFINITY TECHNOLOGIES INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BIAF - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -11.69M
3/31/2025$ -9.74M
12/31/2024$ -9.04M
9/30/2024$ -8.45M
6/30/2024$ -8.74M
3/31/2024$ -8.37M
12/31/2023$ -7.94M
9/30/2023$ -7.24M
6/30/2023$ -9.87M
3/31/2023$ -8.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -6.33M.
  • Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average Cons. Inc. has been $ -8.65M.
  • The median Cons. Inc. for BIOAFFINITY TECHNOLOGIES INC during this period was $ -8.41M
  • BIOAFFINITY TECHNOLOGIES INC reached its highest Cons. Inc. over the past 5 years at $ -6.33M.
  • The lowest Cons. Inc. recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe $ -11.69M

BIOAFFINITY TECHNOLOGIES INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ISPC : ISPECIMEN INC $ -10.19MIVF : INVO FERTILITY INC $ -27.94MBNBX : APPLIED DNA SCIENCES INC $ -13.3MNUWE : NUWELLIS INC $ -14.68MBMRA : BIOMERICA INC $ -4.97MHIND : VYOME HOLDINGS INC $ -4.5MINM : INMED PHARMACEUTICALS INC $ -8.16MCSCIF : COSCIENS BIOPHARMA INC $ -18.84MEVOK : EVOKE PHARMA INC $ -5.38MCPHI : CHINA PHARMA HOLDINGS INC $ -3.66M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

BIAF - Consolidated Income, Last 5 years

$ -11.69M

Minimum

Jun 30, 2025

$ -6.33M

Maximum

Dec 31, 2021

$ -8.65M

Average

$ -8.41M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M